Tak Jin Wook, Gupta Biki, Thapa Raj Kumar, Woo Kyu Bong, Kim Sung Yub, Go Toe Gyeong, Choi Yongjoo, Choi Ju Yeon, Jeong Jee-Heon, Choi Han-Gon, Yong Chul Soon, Kim Jong Oh
College of Pharmacy, Yeungnam University, 214-1, Dae-Dong, Gyeongsan, 712-749, South Korea.
College of Pharmacy, Institute of Pharmaceutical Science and Technology, Hanyang University, 55, Hanyangdaehak-ro, Sangnok-gu, Ansan, 426-791, South Korea.
AAPS PharmSciTech. 2017 May;18(4):1125-1134. doi: 10.1208/s12249-016-0580-5. Epub 2016 Jul 11.
The aim of our current study was to characterize and optimize loxoprofen immediate release (IR)/sustained release (SR) tablet utilizing a three-factor, three-level Box-Behnken design (BBD) combined with a desirability function. The independent factors included ratio of drug in the IR layer to total drug (X ), ratio of HPMC to drug in the SR layer (X ), and ratio of Eudragit RL PO to drug in the SR layer (X ). The dependent variables assessed were % drug released in distilled water at 30 min (Y ), % drug released in pH 1.2 at 2 h (Y ), and % drug released in pH 6.8 at 12 h (Y ). The responses were fitted to suitable models and statistical validation was performed using analysis of variance. In addition, response surface graphs and contour plots were constructed to determine the effects of different factor level combinations on the responses. The optimized loxoprofen IR/SR tablets were successfully prepared with the determined amounts of ingredients that showed close agreement in the predicted and experimental values of tablet characterization and drug dissolution profile. Therefore, BBD can be utilized for successful optimization of loxoprofen IR/SR tablet, which can be regarded as a suitable substitute for the current marketed formulations.
我们当前研究的目的是利用三因素、三水平的Box-Behnken设计(BBD)结合合意函数来表征和优化洛索洛芬速释(IR)/缓释(SR)片。独立因素包括IR层中药物与总药物的比例(X₁)、SR层中羟丙甲纤维素与药物的比例(X₂)以及SR层中丙烯酸树脂RL PO与药物的比例(X₃)。评估的因变量为30分钟时在蒸馏水中的药物释放百分比(Y₁)、2小时时在pH 1.2中的药物释放百分比(Y₂)以及12小时时在pH 6.8中的药物释放百分比(Y₃)。将响应拟合到合适的模型,并使用方差分析进行统计验证。此外,构建响应面图和等高线图以确定不同因素水平组合对响应的影响。使用确定量的成分成功制备了优化的洛索洛芬IR/SR片,该片剂在片剂表征和药物溶出曲线的预测值与实验值方面显示出密切一致性。因此,BBD可用于成功优化洛索洛芬IR/SR片,其可被视为当前市售制剂的合适替代品。